Investing in the “Magnificent Seven?” Pick Your Poison: Negative Free Cash Flow or an Unjustifiable Valuation.
Key Points Although the Magnificent Seven have traditionally done the heavy lifting on Wall Street, all but one have underperformed the benchmark S&P 500 in 2026. Investors are getting fed up with otherworldly spending on artificial intelligence (AI) and punishing companies with negative free cash …